Taro Pharmaceuticals U.S.A. Issues Voluntary Nationwide Recall of Phenytoin Oral Suspension USP, 125 mg/5ml
URGENT: Voluntary Nationwide Drug Recall
|Description ||NDC ||Lot # ||Exp Date|
|PHENYTOIN ORAL SUSPENSION 125MG/5ML ||51672406901 ||327876 ||12/31/2020|
|PHENYTOIN ORAL SUSPENSION 125MG/5ML ||51672406901 ||327874 ||12/31/2020|
Taro Pharmaceuticals U.S.A., Inc. is voluntarily recalling two (2) lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level. The reason for the recall is that product from these two lots of Phenytoin Oral Suspension may not re-suspend when shaken, as instructed for administration, which could result in under or overdosing. This recall is being conducted with the knowledge of the FDA. A listing of the NDC and impacted lot numbers are identified. Affected product started shipping May 2019.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Taro: Taro Pharmaceuticals 866-705-1553